Literature DB >> 11862084

Indications for corneal transplantation in New Zealand: 1991-1999.

Matthew Edwards1, Gillian M Clover, Nigel Brookes, David Pendergrast, Jayne Chaulk, Charles N J McGhee.   

Abstract

PURPOSE: To identify the indications for keratoplasty in patients supplied with donor tissue through the New Zealand National Eye Bank.
METHODS: Analysis of penetrating and lamellar keratoplasty data collected by the New Zealand National Eye Bank, Auckland, from 1991 to 1999.
RESULTS: In this 9-year period, donor material was supplied for 1370 corneal grafts; 1308 for penetrating keratoplasty, 26 for lamellar keratoplasty, and 36 for unspecified grafts. This accounts for a minimum of 85% of the penetrating keratoplasties performed in New Zealand from 1991 to 1999. The leading indications for penetrating keratoplasty were keratoconus (45.6%), pseudophakic or aphakic corneal edema (17.9%), regraft (8.7%), viral keratitis (7.3%), and trauma (5.5%). The average age of patients was 47.5 years (SD = 22.6) and age distribution was bimodal, with peaks in the 3rd and 8th decades. Keratoconus, regraft, and trauma were significantly more common as indicators for penetrating keratoplasty in male patients than female patients; however, pseudophakic or aphakic corneal edema was more common in female patients.
CONCLUSION: The majority of transplantation surgery in New Zealand is performed using corneal tissue from the New Zealand National Eye Bank. In this representative study, keratoconus is the leading indicator for penetrating keratoplasty in New Zealand, accounting for a higher proportion than in any other published literature. The other indications, age distribution and gender differences correlate with previous reports. These findings suggest that keratoconus leading to transplantation may have increased prevalence in New Zealand.

Entities:  

Mesh:

Year:  2002        PMID: 11862084     DOI: 10.1097/00003226-200203000-00004

Source DB:  PubMed          Journal:  Cornea        ISSN: 0277-3740            Impact factor:   2.651


  19 in total

1.  Acute corneal hydrops in keratoconus: a national prospective study of incidence and management.

Authors:  A Barsam; H Petrushkin; N Brennan; C Bunce; W Xing; B Foot; S Tuft
Journal:  Eye (Lond)       Date:  2015-01-16       Impact factor: 3.775

2.  Fuchs' corneal dystrophy.

Authors:  Allen O Eghrari; John D Gottsch
Journal:  Expert Rev Ophthalmol       Date:  2010-04

3.  Penetrating keratoplasty for keratoconus: visual and graft survival outcomes.

Authors:  Mansour M Al-Mohaimeed
Journal:  Int J Health Sci (Qassim)       Date:  2013-01

Review 4.  The indications and outcome of paediatric corneal transplantation in New Zealand: 1991-2003.

Authors:  H Y Patel; S Ormonde; N H Brookes; L S Moffatt; C N J McGhee
Journal:  Br J Ophthalmol       Date:  2005-04       Impact factor: 4.638

5.  Indications of penetrating keratoplasty in southern India.

Authors:  Laxman Dasar; Chaitra Pujar; Kanwarpal Singh Gill; Madhuri Patil; Mallikarjun Salagar
Journal:  J Clin Diagn Res       Date:  2013-11-10

6.  Trends in the indications for penetrating keratoplasty in Shandong, 2005-2010.

Authors:  Jun-Yi Wang; Li-Xin Xie; Xiu-Sheng Song; Jing Zhao
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

7.  Murine corneal transplantation: a model to study the most common form of solid organ transplantation.

Authors:  Xiao-Tang Yin; Deena A Tajfirouz; Patrick M Stuart
Journal:  J Vis Exp       Date:  2014-11-17       Impact factor: 1.355

8.  Deep anterior lamellar keratoplasty: indications, surgical techniques and complications.

Authors:  Farid Karimian; Sepehr Feizi
Journal:  Middle East Afr J Ophthalmol       Date:  2010-01

Review 9.  Graft failure: III. Glaucoma escalation after penetrating keratoplasty.

Authors:  Emily C Greenlee; Young H Kwon
Journal:  Int Ophthalmol       Date:  2008-06       Impact factor: 2.031

10.  Age distribution of various corneal diseases in China by histopathological examination of 3112 surgical specimens.

Authors:  Xiaohua Li; Liya Wang; Laurie Dustin; Qiucai Wei
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-05-08       Impact factor: 4.799

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.